Three years ago, Walgreens invested in Elizabeth Holmes’ medical technology startup, Theranos. The relationship between the drugstore retailer and Holmes—Theranos’ head, who, as a Stanford dropout, had an origin story worthy of Silicon Valley’s best—marked the public announcement of the company. The New York Times…
Last year, Elizabeth Holmes, the founder of troubled blood-testing company Theranos, was at the top of Forbes’ Richest Self-Made Women list with an estimated net worth of $4.5 billion, making her the
youngest self-made female billionaire. On Wednesday, the magazine revised its estimate to “nothing.”
Elizabeth Holmes, Theranos CEO and founder, our favorite blood-fearing, turtleneck-loving, disruption-preaching and increasingly fraudulent-looking biotech entrepreneur, appears to be facing a blanket ban from her own business sector for at least the next two years.
Two women in the biopharma world have written an open letter to their field, asking execs please not to work with companies that use scantily-clad models to liven up their cocktail parties. “We can’t believe it’s 2016 and we have to spend our time writing this letter,” it begins.
One of the world's most fascinating humans is easily Martine Rothblatt, America's highest-paid female CEO. A futurist and trans woman who cofounded both Sirius Satellite Radio and a biotech company, she's got a robot replica of her wife and believes that soon, tech will allow our consciousnesses to live forever.